Novo Nordisk A/S

(NYSE:NVO)

53.34

-1.54 (-2.81%)

Jan 09 - Close

Open
54.73
High
54.74
Low
53.19
Vol.
150.80K
Mkt Cap
28.19B
52Wk High
73.73
52Wk Low
41.90
Avg. Vol.
178.80K
P/E (Trailing)
15.24
Beta
0.00
Short %
Div. Yield
1.60%

After-Hours 53.33 -0.01 (-0.02%) Fri, 9 Jan 2009 7:40 PM

Company Profile

Novo Nordisk A/S

Novo Alle

Bagsvaerd,

Dominican Republic - Map

Phone: (454) 444-8888

Fax: (454) 449-0555

Website: www.novonordisk.com

CEO: Lars Rebien Sorensen

Employees: 25,516

Sector: Healthcare

Industry Group: Drugs

Industry: Drug Manufacturers - Other

Mfr industrial enzymes & pharmaceuticals

A healthcare company, engaged in the discovery, development, manufacture and marketing of pharmaceutical products. It operates in two segments, Diabetes Care and Biopharmaceuticals.

Recent news for NVO

Members owning NVO also own

DNA (33.33%), GENZ (33.33%), JNJ (33.33%), GILD (33.33%), CELG (33.33%)

Member sentiment (?)    Neutral

Top members owning NVO

* Average monthly return vs. S&P 500